Who is Diana Vagelos?
Diana T. Vagelos ’55 is a philanthropist and community leader who has provided service and financial support for organizations in higher education, culture, the life sciences, and the arts.
How much is Roy Vagelos worth?
$1.3 billion
Vagelos has amassed a net worth of $1.3 billion from his director compensation, according to the Bloomberg Billionaires Index. It’s a rare source of fortune, as the average board member in the U.S. is seldom paid more than $1 million annually, according to data compiled by Bloomberg.
When was Roy Vagelos CEO of Merck?
Dr. Vagelos served as Chief Executive Officer of Merck & Co. Inc., for nine years from July 1985 to June 1994. He joined Merck in 1975 as Senior Vice President of Research and became president of its research division in 1976.
What did Roy Vagelos do?
Roy Vagelos (Figure 1) is best known for leading Merck for 20 years, first as President of research and then later as CEO and Chairman of the Board.
How did Roy Vagelos make his money?
When Roy Vagelos was forced to retire in 1994 as chief executive officer of Merck & Co. at the mandatory age of 65, he feared boredom. So he joined Regeneron Pharmaceuticals Inc.’s board, a move that would make him a billionaire.
When did Roy Vagelos retire from Merck?
1994
In 1975 Dr. Vagelos left academia for industry to head Merck’s Research Laboratories and then became the company’s CEO and Chairman in 1985, serving until his retirement in 1994.
Who is Roy Vagelos?
Dr. P. Roy Vagelos, M.D., C’50, earned his B.S. in chemistry from the College of Arts and Sciences at the University of Pennsylvania and his medical degree from the Columbia University School of Medicine. His career – The Medicine, Science and Merck phenomenon – epitomizes the philosophy behind Penn’s Life Sciences & Management Program.
What is the corporate mailing address for Roy Vagelos?
The corporate mailing address for Dr. Vagelos and other Regeneron Pharmaceuticals executives is 777 OLD SAW MILL RIVER ROAD, TARRYTOWN NY, 10591. Regeneron Pharmaceuticals can also be reached via phone at (914) 847-7000 and via email at [email protected]. Learn More on P. Roy Vagelos’ contact information.
When did Dr Vagelos become CEO of Merck?
He joined Merck in 1975, became a director in 1984, President and Chief Executive Officer in 1985 and Chairman in 1986. Dr. Vagelos retired from all positions with Merck in 1994. Dr. Vagelos was on the Board of Directors of Theravance, Inc. through April 2010.
What happened to Dr Vagelos?
Thereafter, Dr. Vagelos moved from the medical into the academic arena to assume the chairmanship of the Department of Biological Chemistry in Washington University’s School of Medicine, St Louis, MO where he founded and became Director of the University’s Division of Biology and Biomedical Sciences.